| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H2016 |
Comprehensive community support services, per diem |
12,113 |
2,278 |
$5.29M |
| M0123 |
|
16,396 |
667 |
$1.25M |
| T2016 |
Habilitation, residential, waiver; per diem |
9,378 |
533 |
$1.24M |
| H2014 |
Skills training and development, per 15 minutes |
18,114 |
1,042 |
$626K |
| M0122 |
|
4,935 |
200 |
$358K |
| T2020 |
Day habilitation, waiver; per diem |
3,273 |
519 |
$252K |
| M0116 |
|
6,768 |
450 |
$212K |
| S5150 |
Unskilled respite care, not hospice; per 15 minutes |
822 |
113 |
$110K |
| T1002 |
Rn services, up to 15 minutes |
2,936 |
1,585 |
$99K |
| M0360 |
|
730 |
48 |
$89K |
| T2025 |
Waiver services; not otherwise specified (nos) |
1,938 |
329 |
$88K |
| M0299 |
|
2,019 |
865 |
$41K |
| M0171 |
|
480 |
184 |
$34K |
| D0120 |
Periodic oral evaluation - established patient |
100 |
90 |
$29K |
| M0201 |
Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home |
698 |
63 |
$19K |
| M0113 |
|
27 |
25 |
$11K |
| M0240 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses |
77 |
12 |
$8K |
| T1003 |
Lpn/lvn services, up to 15 minutes |
864 |
400 |
$8K |
| M0315 |
|
68 |
62 |
$2K |
| M0307 |
|
21 |
13 |
$358.03 |